最新消息 | Tempus

Tempus Announces Six Abstracts Accepted for Poster Presentation at the 2022 SABCS

KEYWORD: Oncology、SABCS

TEMPUS

2022年12月6日讀畢需時 2 分鐘

Tempus Announces Six Abstracts Accepted for Presentation at the 2022 SITC Annual Meeting

KEYWORD: Oncology、SITC

TEMPUS

2022年11月9日讀畢需時 2 分鐘

Tempus Announces Six Abstracts Accepted for Presentation at the ASCO 2022

KEYWORD: Oncology、ASCO

TEMPUS

2022年11月4日讀畢需時 3 分鐘

Tempus Announces Real-World Data-Driven Program to Accelerate Precision Oncology Research

KEYWORD: AI、DATA、Genomic Sequencing

TEMPUS

2022年10月27日讀畢需時 2 分鐘

GSK Announces Expanded Collaboration with Tempus in Precision Medicine to Accelerate R&D

KEYWORD: AI、Genomic Sequencing、GSK

TEMPUS

2022年10月18日讀畢需時 3 分鐘

Tempus Announces Companion Diagnostic Collaboration with Kartos Therapeutics

KEYWORD: Genomic Sequencing、Clinical Trial、TP53WT

TEMPUS

2022年10月6日讀畢需時 2 分鐘

Tempus Announces Collaboration with the COG to Expand Access to Genomic Testing

KEYWORD: Genomic Sequencing、Clinical Trial

TEMPUS

2022年9月20日讀畢需時 2 分鐘

Tempus Announces Three Abstracts Accepted For Presentation at the ESMO

KEYWORD: Oncology、ESMO

TEMPUS

2022年9月9日讀畢需時 3 分鐘

Tempus Announces Research Collaboration with Intermountain Healthcare to Advance Precision Oncology

KEYWORD: DATA、Genomic Sequencing

TEMPUS

2022年6月16日讀畢需時 2 分鐘

Tempus Announces Sequencing Collaboration with Lilly to Expand Access to Genomic Testing

KEYWORD: Genomic Sequencing

TEMPUS

2022年6月9日讀畢需時 2 分鐘

Tempus CE Marks Its Broad-Panel Genomic Sequencing and Algorithmic Diagnostic Tests

KEYWORD: AI、Genomic Sequencing

TEMPUS

2022年6月7日讀畢需時 3 分鐘

Tempus Announces 14 Abstracts Accepted For Presentation at the American Society of Clinical Oncology

KEYWORD: AI、Clinical Trials、DATA、Genomic Sequencing

TEMPUS

2022年6月6日讀畢需時 3 分鐘

Tempus to Launch Largest Clinically Available Liquid Biopsy Panel, xF+

KEYWORD: Genomic Sequencing、Product Launch

TEMPUS

2022年6月3日讀畢需時 2 分鐘

Tempus Announces Agreement With the United States Department of Veterans Affairs National Precision

KEYWORD: AI、Genomic Sequencing

TEMPUS

2022年5月6日讀畢需時 2 分鐘

Tempus Announces Abstracts Accepted For Presentation at the American Association for Cancer Researc

KEYWORD: AI、Genomic Sequencing

TEMPUS

2022年4月8日讀畢需時 2 分鐘

Tempus’ Edge Platform Leverages Data & AI to Identify Therapeutic Options for Patients Earlier in th

KEYWORD: AI、DATA、Product Launch

TEMPUS

2022年3月21日讀畢需時 2 分鐘

Tempus Announces the Acquisition of Highline Sciences

KEYWORD: Clinical Trials

TEMPUS

2022年2月8日讀畢需時 2 分鐘

Tempus Announces Open Enrollment for Study in Collaboration with GSK to Evaluate Niraparib in Advan

KEYWORD: Clinical Trials、Solid Tumor、Genomic Sequencing、Germline

TEMPUS

2022年1月13日讀畢需時 2 分鐘

Tempus Announces Agreement with Janssen R&D to Leverage AI/ML and Real-World Evidence to Enhance the

KEYWORD: Clinical Trials、Genomic Sequencing

TEMPUS

2021年12月1日讀畢需時 2 分鐘

Tempus Signs Strategic Collaboration Agreement with AstraZeneca to Advance Oncology Therapeutics

KEYWORD: AstraZeneca

TEMPUS

2021年11月19日讀畢需時 2 分鐘